Acute myocarditis
Multi-national, double-blind, randomized, placebo-controlled trial designed to study the safety and tolerability of CardiolRx, as well as its impact on myocardial recovery in patients presenting with acute myocarditis.
cardiolrx.comCrawled Oct 30, 2026
Multi-national, double-blind, randomized, placebo-controlled trial designed to study the safety and tolerability of CardiolRx, as well as its impact on myocardial recovery in patients presenting with acute myocarditis.
Cardiol Therapeutics focuses on bringing medicines to patients with heart disease, using clinical trials to assess safety and efficacy with healthcare professionals, patients, and volunteers.
Complete the form below to gain access to the replay of the MAVERIC Trial Investigator & Study Coordinator Meeting.
Dr. Andrew Hamer brings 30 years of experience in the global life sciences industry, medical affairs, and cardiology practice to the Company.
Mr. Lim has a proven track record of over thirty years as a senior executive leading life sciences companies spanning biotechnology, diagnostics, medical devices, and high-technology companies in North America and Europe.
Chris Waddick has over thirty years of experience in financial and executive roles in biotechnology and energy, including public company management, corporate governance, and financial infrastructure design.
Mr. Stott is a veteran of the pharmaceutical and biotech industries, having almost 30 years’ experience in pre-clinical and clinical development, with specific expertise in the development of cannabinoid-based medicines, and 19 years’ experience in the field.
Mr. David Elsley is a business leader with a proven track record of developing, financing and managing all aspects of corporate development in biotechnology and high-growth organizations.
Board certified in cardiovascular disease and Advanced Heart Failure/Transplant Cardiology, Dr. Guillermo Torre-Amione is former chief of the Heart Failure Division and former medical director of Cardiac Transplantation at the Houston Methodist DeBakey Heart & Vascular Center.
The company develops therapies in clinical trials that target inflammatory and fibrotic mechanisms to promote healing for intended patients.
Cardiol Therapeutics is a clinical-stage company developing anti-inflammatory and anti-fibrotic therapies for heart disease treatment.